Celladon Corp. plans to raise $40 million by offering 5 million shares at $8 per share in its upcoming initial public offering, according to Renaissance Capital.
In November of 2013, Celladon had announced a $75 million IPO, with plans to release 5 million shares of stock at a price range of $14 to $16 per share. The company later postponed the IPO citing poor market conditions.
Celladon is planning to list on the NASDAQ under the symbol “CLDN.” Barclays is the sole bookrunner on the deal. It is expected to price during the week of Jan. 27, according to Renaissance Capital.
SDBJ Staff Report